// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Pre-operative FDG PET-CT predicts outcome following curative-intent resection for peri-hilar cholangiocarcinoma; is routine FDG PET-CT indicated for all patients?

I. Wijetunga - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

Portoenterostomy as a salvage procedure for major biliary complications following hepaticojejunostomy

A. Sharma - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predictive factors for malignant biliary strictures in patients with a normal bilirubin and/or normal liver enzymes

S. Thomasset - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluation of the endothelial marker CD105 as a prognostic biomarker and target for molecular imaging in perihilar cholangiocarcinoma

A. Nair - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Neutrophil gelatinase associated lipocalin (NGAL) as a theragnostic biomarker for perihilar cholangiocarcinoma

A. Nair - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Patients with an age greater than 60 years undergoing liver resection for colorectal liver metastases; an independent prognostic factor of an increased postoperative non-surgical complication rate and of decreased overall survival

A. Giakoustidis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Outcome following resection of biliary cystadenoma: A single centre experience

M. Pitchaimuthu - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Measuring liver function with gadoxetic acid: Is a dual-inlet model needed in dynamic contrast enhanced liver mri?

D.A. Longbotham - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Gadoxetic acid

Selective internal radiation therapy for the management of primary and secondary liver malignancies in palliative and downsizing scenarios

J. Moir - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Dielectric spectroscopy: Can we separate normal liver tissue from steatotic, cirrotic or malignant?

M. okic - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Variations and adaptations of alpp Many routes to the summit!

M. Edmondson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

No difference in survival for r1 resection Could there be a role for debulking surgery for colorectal liver metastases?

A. Powell-Chandler - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of portal vein embolisation on early outcomes from right and extended right hepatectomy

H. Nageswaran - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Conventional tumour markers in liver cyst fluid aspirate cannot differentiate between simple liver cysts and mucinous cystic neoplasms of the liver

P.L. Labib - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Bi-institutional case-matched comparison of short-term clinical outcomes of radiofrequency-assisted liver partition and portal vein ligation (RALPP) and associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)

M.H. Sodergren - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ALPPS monosegment resections allow a further extension of the limitations of resectability in colorectal liver metastases

E. Schadde - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

A rare presentation of cholangiocarcinoma – Isolated intrahepatic duct dilatation

C. Jones - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Implementation of an enhanced recovery pathway after liver resection: Single centre UK experience

B. Dasari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cytoreductive surgery and heated intraperitoneal chemotherapy with synchronous liver resection

R. Fish - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Surgical management of hepatocellular carcinoma – The northern ireland perspective

N. Hope - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Copyright © 2026. QuantiNova All rights reserved